Eli Lilly And Co (LLY) Taltz Has A Higher Response Rate Than Stelara For Psoriasis
Detailed results from the IXORA-S study have revealed that Taltz (ixekizumab) has superior efficacy compared to Stelara (ustekinumab).
Posts Tagged ‘Is LLY A Good Stock To Buy Right Now?’
Trulicity Label From Eli Lilly And Co (LLY) Will Be Used In Combination With Basal Insulin
The once per week Trulicity label from Eli Lilly and Co (NYSE:LLY) has been updated. The changes, which have been approved by the U.S.
Can Acorda Therapeutics Inc (ACOR) Give Eli Lilly And Co (LLY) A Run For Its Money In Migraine Drug Market?
Acorda Therapeutics Inc (NASDAQ:ACOR) inhaled migraine candidate CVT-427 is seen by Janney analyst Ken Trbovich as likely to give Eli Lilly and Co (NYSE:LLY) severe competition...
Here’s What You Need To Know About The Eli Lilly And Co (LLY) And CoLucid Pharmaceuticals Inc (CLCD) Deal
Eli Lilly and Co (NYSE:LLY) just announced that it is set to acquire junior biotech CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) in a deal worth up to $960 million.
Gilead Sciences, Inc. (GILD) Is A Hail Mary: 3 Better Stocks To Consider
After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead Sciences, Inc.
AstraZeneca PLC (ADR) (AZN) Cuts Jobs, Signs New Collaboration With Eli Lilly And Co (LLY)
“By diligently prioritizing, we will continue to successfully launch and commercialize new medicines, meet the needs of our customers and patients, and ultimately help AstraZeneca...
Eli Lilly And Co (LLY) Discusses Job Cuts
Eli Lilly and Co (NYSE:LLY) has recently confirmed that it will cut jobs following the release of disappointing results from a clinical trial evaluating solanezumab, affecting...
Here’s Why These Two Biotechs Just Took A Hit: Eli Lilly And Co (LLY) And Juno Therapeutics Inc (JUNO)
As the markets take a break for Thanksgiving, things settled down a little bit late-Wednesday, but not before some sharp shocks in the biotech sector.
Biogen Inc (BIIB) Stock Tumbles In Sympathy To Eli Lilly And Co (LLY), C’mon Man!
Biogen Inc (NASDAQ:BIIB) stock is getting whacked in sympathy to Eli Lilly and Co (NYSE:LLY)'s announcement that it has once again failed in its quest to prove solanezumab to ...
Eli Lilly And Co (LLY) Stock: Falling Apart On Failed Study
Eli Lilly And Co (NYSE:LLY) is having an incredibly rough day in the market today.
Eli Lilly and Co (LLY) Gets Dedicated Humulin R U-500 Insulin Syringe From Becton Dickinson
The Humulin R U-500 insulin is prescribed to patients who need a higher dose of insulin on a daily basis.
Eli Lilly And Co (LLY) Is Awaiting the FDA’s Nod Over a New Indication for Jardiance
Eli Lilly and Co (NYSE:LLY) has categorically stated to its regulators and investors that it is hanging onto a possible nod from the FDA for a new indication for Jardiance.
Inside The FDA: Eli Lilly and Co (LLY) Jardiance Aims at Proving Cardiovascular Benefit in Diabetes, Will FDA Agree?
On June 28, 2016, the Endocrinologic and Metabolic Drugs Advisory Committee of the Food and Drug Administration (FDA) met to discuss and vote upon a supplemental New Drug Application...
The Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All
At the turn of the millennium, the population of the United States clocked in at 282.2 million.
